Myelodysplastic Syndrome (MDS)
Showing 51 - 75 of 77
AML-MDS Novel Prognostic Tests Clinical Study
Unknown status
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Calgary, Alberta, Canada
- +5 more
Jan 30, 2017
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Cranbury (CPI-613)
Withdrawn
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Cranbury, New JerseyCornerstone Pharmaceuticals, Inc
Dec 27, 2016
Myelodysplasic Syndromes and Risk Factors for Infection
Unknown status
- Myelodysplastic Syndrome (MDS)
- +3 more
- No intervention
-
Creteil, FranceHenri Mondor Hospital
Dec 20, 2016
Myelodysplastic Syndrome (MDS) Trial in Toronto
Unknown status
- Myelodysplastic Syndrome (MDS)
-
Toronto, Ontario, CanadaOdette Cancer Center
Nov 15, 2016
Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)
Terminated
- Myelodysplastic Syndrome (MDS)
- Chronic Myelomonocytic Leukemia (CMML)
- birinapant
- +2 more
-
Glendale, Arizona
- +75 more
Oct 18, 2016
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Treosulfan)
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Birmingham, Alabama
- +22 more
Oct 10, 2016
Myelodysplastic Syndrome (MDS) Trial in Houston (TXA127)
Terminated
- Myelodysplastic Syndrome (MDS)
-
Houston, TexasMD Anderson Leukemia Department
Aug 29, 2016
Acute Myelogenous Leukemia (AML), Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS) Trial in Chicago, Ann Arbor, Fairfax
Unknown status
- Acute Myelogenous Leukemia (AML)
- +3 more
- Sargramostim
- +2 more
-
Chicago, Illinois
- +2 more
Apr 18, 2016
Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Chronic Myelogenous Leukemia (CML) Trial
Completed
- Acute Myeloid Leukemia in Remission
- +7 more
- POL6326
- +2 more
-
Kansas City, Kansas
- +1 more
Feb 25, 2016
Leukemias, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL) Trial in Chapel Hill (Terameprocol (EM-1421))
Terminated
- Leukemias
- +7 more
- Terameprocol (EM-1421)
-
Chapel Hill, North CarolinaUNC, Lineberger Comprehensive Cancer Center
Feb 20, 2016
Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)
Suspended
- Myelodysplastic Syndrome (MDS)
- Myelofibrosis (MF)
- KB004, Monoclonal Antibody
-
Palo Alto, California
- +8 more
Nov 13, 2015
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Canada, United Kingdom, United States (Azacitidine,
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Houston, Texas
- +7 more
Apr 22, 2015
Hematologic Malignancy, Myelodysplastic Syndrome (MDS), Aplastic Anemia Trial in Durham (haplo/cord transplant)
Completed
- Hematologic Malignancy
- +2 more
- haplo/cord transplant
-
Durham, North CarolinaDuke University Medical Center Pediatric Blood and Marrow Transp
Mar 16, 2015
Myelodysplastic Syndrome (MDS) Trial in Worldwide (Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG))
Terminated
- Myelodysplastic Syndrome (MDS)
- Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)
-
Paris, France
- +6 more
Mar 17, 2015
Chimerism in Refractory Cytopenia Transplanted With Reduced
Completed
- Refractory Cytopenia of Childhood
- +3 more
-
Frankfurt am Main, Hessen, GermanyUniversity Children´s Hospital
Jan 14, 2015
Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) Trial in Durham (WT1
Terminated
- Acute Myelogenous Leukemia (AML)
- +4 more
- WT1 derived peptides
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Dec 7, 2013
Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))
Terminated
- Myelodysplastic Syndrome (MDS)
- ezatiostat hydrochloride (Telintra®)
-
Maywood, Illinois
- +4 more
Nov 20, 2013
Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))
Terminated
- Myelodysplastic Syndrome (MDS)
- ezatiostat hydrochloride (Telintra®)
-
Concord, California
- +6 more
Nov 20, 2013
Blood And Marrow Transplantation, Leukemia, Lymphoma Trial in United States (Fludarabine, Clofarabine, Busulfan, ATG, TBI
Unknown status
- Blood And Marrow Transplantation
- +6 more
- Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative)
- Fludarabine, Melphalan, ATG (Reduced Intensity)
-
La Jolla, California
- +3 more
Nov 14, 2013
Myelodysplastic Syndrome (MDS) Trial in Decatur, Huntsville (Arsenic Trioxide)
Terminated
- Myelodysplastic Syndrome (MDS)
- Arsenic Trioxide
-
Decatur, Alabama
- +1 more
Oct 10, 2012
Myelodysplastic Syndrome (MDS) Trial in Maywood, Worcester (Ezatiostat Hydrochlorine)
Completed
- Myelodysplastic Syndrome (MDS)
- Ezatiostat Hydrochlorine
-
Maywood, Illinois
- +2 more
May 30, 2012
Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)
Completed
- Myelodysplastic Syndrome (MDS)
- Ezatiostat Hydrochloride
-
Tucson, Arizona
- +35 more
Oct 10, 2011
Myelodysplastic Syndrome (MDS) Trial in United States (lintuzumab, lenalidomide)
Completed
- Myelodysplastic Syndrome (MDS)
-
Birmingham, Alabama
- +7 more
Oct 7, 2011
Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Paris (5 azacytidine - VALPROIC acid- Retinoic acid)
Completed
- Acute Myelogenous Leukaemia (AML)
- Myelodysplastic Syndrome (MDS)
- 5 azacytidine - VALPROIC acid- Retinoic acid
-
Paris, FranceChu Saint Louis
May 6, 2011